|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�,Ѱ�� |
|
�����˾� |
|
������ |
|
ҩ�������� |
| ��������������� | |
|
����ƽ |
|
��¡�� |
| PubMed | |
|
Article by |
|
Article by |
����������˾���ҩ�Ե��о���չ
����ƽ, ��¡��
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о��� �Ͼ� 210042
�����˾��������������Ҫ���á��ֲ���ϵͳʹ�ÿ��������������֢����,ȡ���˺ܺõ���Ч��Ȼ��,�������й������˾���ҩ���������ʧ�ܵı����������ࡣ�����������˾���������е����á���ҩ��״���䷢������,�Լ�����ܹ������ܼ��ٻ������ҩ���IJ���,�Ӷ����ҩ����Ч��
[2] Holland KT, Aldana O, Bojar RA, et al. Propionibacterium acnes and acne. Dermatology, 1998, 196:67-68.
[3] Webster GF. Inflammatory acne represents hypersensitivity to Propionibacterium acnes. Dermatology, 1998, 196:80-81.
[4] Webster GF, Leyden JJ, Norman ME, et al. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun, 1978, 22:523-529.
[5] Nishijima S, Kurokawa I, Katoh N, et al. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. J Dermatol, 2000, 27:318-323.
[6] Eady EA. Bacterial resistance in acne. Dermatology, 1998, 196:59.
[7] Tan HH, Goh CL, Yeo MG, et al. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore. Ann Acad Med Singapore, 2001, 30:22-25.
[8] Ross JI, Snelling AM, Carnegie E,et al. Antibiotic-resistant acne:lessons from Europe. Br J Dermatol, 2003, 148:467-478.
[9] Tan HH. Antibacterial therapy for acne: a guide to selection and use of systemic agents. Am J Clin Dermatol, 2003, 4:307-314.
[10] Eady EA, Jones CE, Tipper JL, et al. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage.BMJ, 1993, 306:555-556.
[11] Espersen F. Resistance to antibiotics used in dermatological practice.Br J Dermatol, 1998, 139:4-8.
[12] Westh H, Hougaard DM, Vuust J, et al. Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988. Antimicrob Agents Chemother, 1995, 39(2):369-373.
[13] Ross JI, Eady EA, Cove JH, et al. Resistance to erythromycin and clindamycin in cutaneous propionibaeteria is associated with mutations in 23S rRNA. Dermatology, 1998, 196:69-70.
[14] Ross JI, Snelling AM, Eady EA, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U. S.A., Japan and Australia. Br J Dermatol, 2001, 144:339-346.
[15] Roberts MC. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution.FEMS Microbiol Rev, 1996, 19:1-24.
[16] Goulden V. Guidelines for the management of acne vulgaris in adolescents. Paediatr Drugs, 2003, 5:301-313.
[17] Nam C, Kim S, Sim Y, et al. Anti-acne effects of Oriental herb extracts: a novel screening method to select anti-acne agents. Skin Pharmaeol Appl Skin Physiol, 2003, 16:84-90.
[18] Ashkenazi H, Malik Z, Harth Y, et al. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol, 2003,35:17-24.